Actively Recruiting

Phase Not Applicable
All Genders
Healthy Volunteers
NCT07255300

Follow up Study of Varapodio Trial: Effect of Longevity and Fasting Mimicking Diet on Risk Factors Age Correlated and Biomarkers of Aging

Led by Fondazione Valter Longo · Updated on 2025-12-01

135

Participants Needed

1

Research Sites

108 weeks

Total Duration

On this page

Sponsors

F

Fondazione Valter Longo

Lead Sponsor

U

Universita degli Studi di Palermo

Collaborating Sponsor

AI-Summary

What this Trial Is About

A large ongoing randomized, open-label trial aimed at evaluating the effects of two different dietary interventions, FMD and LD, on body composition and cardiovascular (CV) biomarkers in a real word population (NCT05698654) is actually ongoing. This trial started in January 2024 will enrol 501 adult subjects between the ages of 30 and 65: 167 subjects randomized to the FMD arm with a 5-day meal program once every three months for a 6-month period (arm 1); 167 subjects randomized to follow the FMD plus a Longevity Diet program (FMD+LD) for a 6-month period (arm 2); 167 randomized to the control group (arm 3) that will continue their usual diet. On 2024,410, participants were enrolled and randomly assigned to FMD, FMD + LD, or control arm. Although preliminary data demonstrated the beneficial effects of such nutritional plans on body weight, BMI, body composition, and cardiovascular (CV) biomarkers, limited data is available on the long-term effects of these powerful nutritional interventions.

CONDITIONS

Official Title

Follow up Study of Varapodio Trial: Effect of Longevity and Fasting Mimicking Diet on Risk Factors Age Correlated and Biomarkers of Aging

Who Can Participate

All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 30 to 65 years
  • Participants who completed a previous FMD-based clinical trial less than 6 months ago
  • Willingness to continue the FMD program for an additional 12 months
  • Ability to comply with study visits and procedures
Not Eligible

You will not qualify if you...

  • Having a family member already enrolled in the study
  • Allergy to tree nuts (macadamia, cashew, almond, pecan), soy, oats, sesame, or celery/celeriac
  • Pregnancy or breastfeeding
  • Cancer diagnosis within the past 5 years
  • Myocardial infarction or stroke within the past 5 years
  • Chronic steroid use longer than 45 consecutive days
  • Insulin-dependent diabetes or use of insulin or insulin-like drugs
  • Use of hypoglycemic agents other than metformin
  • Severe hypertension (systolic > 200 mmHg or diastolic > 105 mmHg)
  • Recent changes in medications, use of narcotics, corticosteroids, anticoagulants (except aspirin), or neuroactive medications within specified timeframes
  • Known allergies or intolerance to study products
  • Clinically significant vital sign abnormalities
  • Serious unstable illnesses including cardiac, hepatic, renal, gastrointestinal, respiratory, endocrinologic, neurologic, immunologic, or hematologic diseases
  • Known infection with HIV, TB, or Hepatitis B or C
  • History or current diagnosis of cardiovascular disease, autoimmune diseases, significant liver/kidney disease, malignancy (except treated >2 years ago), or serious mental illness
  • Use of drugs of abuse within 15 days prior to study start
  • Regular intake of excess alcohol (>14 drinks/week for females, >21 drinks/week for males)
  • Conditions preventing bioelectrical impedance testing (e.g., prostheses, pacemakers)
  • Inability to comply with study or follow-up visits
  • Abnormal laboratory findings outside specified ranges
  • Women of childbearing potential must use contraception and have negative pregnancy test prior to enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ambulatorio Medico presso Biblioteca Comunale

Varapodio, Calabria, Italy, Italy, 89010

Actively Recruiting

Loading map...

Research Team

R

Romina Inés Cervigni

CONTACT

A

Alberto Montesanto

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here